- Home
- VRCA vs PVL Comparison
VRCA vs PVL Comparison
Compare VRCA & PVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VRCA | PVL |
|---|---|---|
| Founded | 2013 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.7M | 57.8M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | VRCA | PVL |
|---|---|---|
| Price | $8.14 | $1.87 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 383.9K | 80.3K |
| Earning Date | 11-14-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 19.25% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.06 |
| Revenue | ★ $30,829,000.00 | $3,511,891.00 |
| Revenue This Year | $373.65 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $29.20 |
| Revenue Growth | ★ 234.73 | 11.77 |
| 52 Week Low | $3.28 | $1.30 |
| 52 Week High | $10.50 | $2.04 |
Technical Indicators
Market Signals| Indicator | VRCA | PVL |
|---|---|---|
| Relative Strength Index (RSI) | 67.02 | 60.52 |
| Support Level | $6.26 | $1.82 |
| Resistance Level | $9.78 | $1.83 |
| Average True Range (ATR) | 1.12 | 0.06 |
| MACD | 0.37 | 0.01 |
| Stochastic Oscillator | 75.22 | 86.67 |
Price Performance
Historical ComparisonAbout VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.
About PVL Permianville Royalty Trust Trust Units
Permianville Royalty Trust is a statutory trust which holds net profits interests in the profits from the sale of oil and natural gas production from non-operated assets of both conventional properties in the States of Texas, Louisiana, and New Mexico as well as unconventional assets in the Permian and Haynesville basins.